Items where Author is "Hanley, KP"
 | Up a level |
Group by: Item Type | No Grouping
Number of items: 2.
Raza, S
Jokl, E
Pritchett, J 
ORCID: https://orcid.org/0000-0003-2620-7061
Martin, K
Su, K
Simpson, K
Birchall, L
et al.
ORCID: https://orcid.org/0000-0003-2620-7061
Martin, K
Su, K
Simpson, K
Birchall, L
et al.
Raza, S, Jokl, E, Pritchett, J ORCID: https://orcid.org/0000-0003-2620-7061, Martin, K, Su, K, Simpson, K, Birchall, L, Mullan, AF, Athwal, VS, Doherty, DT, Zeef, L, Henderson, NC, Kalra, PA, Hanley, NA and Hanley, KP
(2021)
SOX9 is required for kidney fibrosis and activates NAV3 to drive renal myofibroblast function.
Science Signaling, 14 (672).
ISSN 1945-0877
ORCID: https://orcid.org/0000-0003-2620-7061, Martin, K, Su, K, Simpson, K, Birchall, L, Mullan, AF, Athwal, VS, Doherty, DT, Zeef, L, Henderson, NC, Kalra, PA, Hanley, NA and Hanley, KP
Pritchett, J, Harvey, E, Athwal, V, Berry, A, Rowe, C, Oakley, F, Moles, A, Mann, DA, Bobola, N, Sharrocks, AD, Thomson, BJ, Zaitoun, AM, Irving, WL, Guha, IN, Hanley, NA and Hanley, KP
(2012)
Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans.
Hepatology, 56 (3).
pp. 1108-1116.
ISSN 0270-9139